Navigation Links
CEM Wins Peptide Patent Dispute with Biotage
Date:5/9/2013

MATTHEWS, N.C., May 9, 2013 /PRNewswire/ -- CEM Corporation, a leading global provider of microwave laboratory instrumentation is pleased to announce that its European Patent No. 1 491 552 covering microwave assisted solid phase peptide synthesis has been upheld in an oral proceeding at the European Patent Office. The opposition proceeding had been initiated by Biotage in an attempt to revoke the patent. The patent broadly covers the overall process of microwave peptide synthesis including the steps of deprotection and coupling. Biotage was unable to find or provide any new prior art that could be used to nullify the patent.

(Logo: http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b

"We are very pleased with the outcome of the examination and with the result that the patent has been fully upheld," commented Michael J. Collins , PhD., president and CEO of CEM Corporation.  "This confirms the fact that the patent is valid and enforceable.  Microwave peptide synthesis, which was developed by CEM, has been shown to dramatically reduce cycle times and increase purity particularly for difficult sequences. It has become a major new enabling technology for the peptide community."

"Microwave peptide synthesis using the methods claimed in EP 1 491 552 can only be performed using CEM microwave systems which carry a license for this process," Collins continued.  "No other microwave systems (including Biotage) can be offered or used to perform CEM's patented microwave peptide synthesis (including deprotection and coupling) without being in violation of this or other related CEM patents. Obviously, we will continue to ensure that all of our intellectual property rights are fully enforced and protected.

"CEM has similar issued patents in the United States, Canada, and Japan. In addition to these process patents, we have a number of issued and pending hardware and chemistry patents related to this field. We also have a major on-going Research and Development effort aimed at expanding the knowledge base and creating next generation technology for peptide synthesis.   

"Our goal is to be the worldwide leader in providing unique and innovative solutions for doing peptide synthesis using our core microwave technology. We have a number of exciting new developments related to both hardware and chemistry innovation that will be coming to market in the next year," Collins concluded.  

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom & Ireland, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.

http://www.cem.com/ 


'/>"/>
SOURCE CEM Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
3. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
4. QYresearchReports.com - Global and China Synthesis Polypeptide Drug Industry 2012 Deep Research Report
5. US Peptides Increases Inventory on Sterile Bacteriostatic Water
6. IGF-1 and Long IGF-1 LR3 Is There a Difference? US Peptides Discusses
7. US Peptides Provides New Article Discussing HGH and Athletic Performance
8. New Florida Peptides Site offering CJC-1295, GHRP-6, Sermorelin and more!
9. US Peptides Discusses IGF 1 in new article series
10. Tarix Pharmaceuticals Peptide Technology Stimulates Revascularization Following Ischemia
11. Alzheimers Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... 2016  The Addiction Treatment Advisory Group (ATAG), ... Care Pharmacy (AMCP), has released detailed findings on ... opioid addiction crisis, including through improved access to ... ATAG,s newly released paper, "The Role of Managed ... many issues around gaps and barriers to addiction ...
(Date:12/2/2016)... 2, 2016 Boston Scientific Corporation (NYSE: ... acquire certain manufacturing assets and capabilities of the Neovasc, ... biological tissue business, as well as a 15% equity ... in cash. The Neovasc advanced biological tissue business makes ... Scientific Lotus™ Valve System. * Upon completion of ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative teams ... Family Partnership and the Drug Enforcement Administration as part of the National Red Ribbon ... winning schools who decorated their campuses with this year’s Red Ribbon Week theme: “YOLO. ...
(Date:11/30/2016)... ... November 30, 2016 , ... Northridge ... in-house dental plan for all patients. Understanding that budget can play a part ... a number of perks, including discounts on many valuable dental treatments. Options for ...
(Date:11/30/2016)... Wisconsin (PRWEB) , ... November 30, 2016 , ... ... in the 2016 Deloitte Wisconsin 75, an annual ranking and recognition of the ... year on the list, having ranked from 2008-2016. In addition, Standard Process was ...
(Date:11/30/2016)... (PRWEB) , ... November 30, 2016 , ... ... and mental health treatment has announced the opening of a new residential mental ... for girls with mental health issues such as severe anxiety, depression, bi-polar disorder, ...
(Date:11/30/2016)... ... November 30, 2016 , ... The ... stylish design wanted by today’s consumers at an affordable price, is now available ... the new watch is “a game changer” when it comes to the smartwatch. ...
Breaking Medicine News(10 mins):